Navigation Links
China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
Date:9/10/2007

holding.net

Investor Relations International (Los Angeles)

Haris Tajyar

Managing Director

Tel: +1-818-382-9700

Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.


'/>"/>
SOURCE China Holdings, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...cent research findings suggest that reflecting on ...logical responses to stress at low levels. Stress ... of a broad array of mental and physical health di...on the self suggest that self-affirming activities...
...ofessor Bruno DiGiovine and colleagues from Henry ...ople with lung cancer declined their interest to u...er rate than the white colored//. The study found ...s of lung cancer surgery and this misinformation h...
...riodontal disease is one of the main causes of too...ority of the tooth extractions (those with periodo...for those without// periodontal disease). It has n...tain groups of people exhibit increased susceptibi...
...lmon is considered a health food by many, because ..., its protein. A study compared the benefits of fa...// (mostly pacific salmon). Farmed salmon or Atla...e environmental pollutants such as mercury, PCBs, ...
Other Medicine News:Health News:Blacks decline Lung cancer surgery 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 2Health News:Nine Major Culprits For Tooth Loss Identified By Researchers 3
(Date:10/6/2008)... Improve Patient Safety, WASHINGTON, Oct. 6 /PRNe...iology in collaboration with the American College ...tion today released consensus guidelines,outlining...rs and,gastrointestinal (GI) bleeding among patien...IDs) along with antiplatelet agents., Gastrointes...
(Date:10/6/2008)... Dosed Prior to Surgery, TAMPA, Fla., Oct. 6 /PRN... held ophthalmic-focused biopharmaceutical company...ophthalmic emulsion) 0.05% is now,commercially ava...od and,Drug Administration in June 2008, is a topi...eatment of inflammation and pain associated with o...
(Date:10/6/2008)...irstCall/ -- Genaera,Corporation (Nasdaq: GENR ) ...al trial of trodusquemine (MSI-1436), Genaera,s le...etes and obesity. MSI-1436 is a novel,inhibitor of... the function,of both the leptin and insulin pathw... the study, MSI-1436 was found to be well-tolerate...
(Date:10/6/2008)...patients achieved endoscopic,response and more tha... 10,in data from a 54-week open-label study presen...CG) Annual Scientific Meeting, ORLANDO, Fla., Oct...a,large, prospective study investigating endoscopi...gic compound. The data presented at the American,C...
Breaking Medicine Technology:Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 2Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 3Consensus Document Outlines Practical Steps for Reducing Gastrointestinal Risks of Antiplatelet and NSAID Use 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 2Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 3Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 4Video: Sirion Therapeutics Launches Durezol for Postoperative Ocular Inflammation and Pain 5Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 2Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 3Genaera Corporation Reports Phase 1 Data for Trodusquemine (MSI-1436) at the North American Association for the Study of Obesity Annual Meeting 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 2CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 3CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 4CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 5CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 6CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients 7Industry Executives Finding Value in Shift of Scientific Publications 5484 1Industry Executives Finding Value in Shift of Scientific Publications 5484 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 1Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 2Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials 2104 3Researchers expand natural killer cells in cord blood to fight leukemia 19605 1Researchers expand natural killer cells in cord blood to fight leukemia 19605 2New drug combination brings 1 2 punch against acute leukemia 19604 1New drug combination brings 1 2 punch against acute leukemia 19604 2
...13, 2007, 2007, SAN DIEGO, and SEOUL, South Korea,...euticals, Inc. and LG Life,Sciences, Ltd., present... (LB80380) retains potency against multiple mutant...stant to lamivudine,adefovir, entecavir or telbiv...nual Meeting of the European Association for the S...
...c Hepatitis B e-Antigen,(HBeAg)-Negative Patients ...Treatment, PRINCETON, N.J., April 13, 2007 /PRNews...day announced data from a cohort of,nucleoside-nai...V-027/901, n=99). These data showed that patients ...rus in the blood,after interruption of treatment w...
Other Medicine Technology:ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 2ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 3ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 4ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 5ANA380 Exhibits Activity In Vitro Against Multiple Clinically,Relevant Hepatitis B Virus Mutants 6Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 2Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 3Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 4Baraclude (entecavir) Therapy Resulted in Undetectable Levels of,Hepatitis B Virus in Cohort of Patients Who Re-Started Treatment 5
Bacterial/Viral Filters for Anesthesia and Respiratory Applications
Bacterial/Viral Filters for Anesthesia and Respiratory Applications
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours
Indications For Usage: ,Single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to be replaced at least once every 24 hours.
Medicine Products: